Opportunity Information: Apply for PAR 11 150

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.397 Cancer Centers Support Grants.
  • This funding opportunity was created on Feb 26, 2014 and posted on Mar 14, 2011.
  • Applicants must submit their applications by Feb 26, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) State governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Small businesses Special district governments For profit organizations other than small businesses Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) County governments.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Foreign (non U.S.) components of U.S. Organizations are allowed.
Apply for PAR 11 150

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIH grant opportunity PAR-11-150, titled "Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01)," supports research that improves how tumor response to cancer treatment is measured using medical imaging in clinical trial settings. The central aim is to make imaging-based response assessment more quantitative, reliable, and clinically useful so that it can better inform real clinical decision making, not just exploratory research. The focus is specifically on developing, adapting, and implementing quantitative imaging approaches that can be used in ongoing or planned early-stage clinical therapy trials (Phase 1 and Phase 2). Rather than paying for the clinical trials themselves, this FOA funds the imaging research components that ride alongside those trials, such as the imaging methodology, workflow, and analysis infrastructure needed to extract dependable quantitative measurements.

Projects are expected to work with existing commercial imaging platforms and instrumentation, meaning applicants should generally build practical solutions that can function within real-world clinical environments instead of relying on highly specialized or one-off scanners. The research scope includes developing or refining quantitative imaging methods, standardizing imaging protocols, and creating or improving software tools that enable consistent measurement of therapy response. The quantitative endpoints should be derived from imaging and tied to responses to drugs, radiation therapy, and/or image-guided interventions. In other words, the funded work should concentrate on measurable imaging biomarkers or metrics that track how tumors change with treatment, with an emphasis on approaches that could be validated and used consistently across sites and studies.

Because quantitative response imaging sits at the intersection of oncology, radiology, medical physics, image analysis, and biostatistics, the FOA anticipates that strong applications will be multidisciplinary. It encourages teams that include oncologists along with clinical and basic imaging scientists to ensure the resulting methods are both technically sound and clinically relevant. The opportunity also strongly encourages (but does not require) involvement of industrial partners, reflecting an interest in tools and workflows that can be adopted broadly, integrate with commercial systems, and potentially scale beyond a single institution.

A key structural feature of this program is that awardees will join a broader collaborative effort called the Quantitative Imaging Network (QIN). Through the QIN, funded groups are expected to share ideas, compare approaches, and work toward validation and standardization. This includes not only the imaging measurements themselves but also the supporting imaging metadata, since consistent acquisition parameters, reconstruction settings, and data descriptions are essential if quantitative imaging results are to be comparable across scanners, sites, and trials. In practical terms, the network component signals that NIH is looking for interoperable methods and common standards that can be tested and harmonized across the community, rather than isolated tools that only work within one lab.

The funding mechanism is a U01 cooperative agreement, which typically indicates substantial scientific and programmatic involvement by NIH staff compared to a standard research project grant. The opportunity is listed under NIH and aligns with program areas such as cancer detection and diagnosis research, cancer treatment research, and cancer center support (CFDA numbers 93.394, 93.395, and 93.397). The award ceiling is listed as $500,000, cost sharing is not required, and the opportunity is categorized as discretionary funding within health-related activities. Eligibility is broad and includes many types of organizations, such as universities (public and private), nonprofit organizations (including 501(c)(3) and certain non-501(c)(3) entities), small businesses, for-profit entities other than small businesses, state and local governments, tribal governments and tribal organizations, independent school districts, public housing authorities, and other specified institutions. The eligibility list also explicitly includes certain minority-serving institutions (for example, HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian-serving institutions), faith-based or community-based organizations, and regional organizations. Foreign organizations and non-U.S. components of U.S. organizations are allowed, indicating that international participation is permissible when aligned with the FOA requirements.

In short, this FOA is aimed at accelerating practical, standardized quantitative imaging methods that can be deployed in early-phase cancer therapy trials to measure treatment response more objectively. It prioritizes method development and implementation that fits within clinical workflows, encourages cross-disciplinary and cross-sector collaboration, and requires participation in a network designed to validate, share, and harmonize quantitative imaging data and metadata so the resulting measurements can be trusted and compared across studies.

FAQs: NIH PAR-11-150 - Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01)

What is the purpose of NIH PAR-11-150?

This funding opportunity supports research to improve how tumor response to cancer therapies is measured using medical imaging in clinical trial settings. The goal is to make imaging-based response assessment more quantitative, reliable, and clinically useful so it can inform real clinical decision making, not just exploratory research.

What kinds of studies does this opportunity prioritize?

It prioritizes projects that develop, adapt, and implement quantitative imaging approaches that can be used in ongoing or planned early-stage clinical therapy trials, specifically Phase 1 and Phase 2 trials.

Does this FOA pay for the clinical trial itself?

No. The FOA funds the imaging research components that run alongside clinical trials, such as imaging methodology, workflow integration, and analysis infrastructure needed to produce dependable quantitative measurements.

What is meant by "quantitative imaging" in this program?

In this program, quantitative imaging refers to imaging-based measurements or metrics (imaging endpoints) that objectively track how tumors change with treatment. The emphasis is on measurements that can be made consistently and reliably, and that can be compared across sites and studies.

What types of cancer therapies can the imaging endpoints relate to?

The quantitative imaging endpoints are expected to be tied to responses to drugs, radiation therapy, and/or image-guided interventions.

What types of project activities are within scope?

Activities within scope include developing or refining quantitative imaging methods, standardizing imaging protocols, and creating or improving software tools that support consistent measurement of therapy response.

Are applicants expected to use specialized research scanners or custom-built imaging systems?

No. Projects are expected to work with existing commercial imaging platforms and instrumentation, with an emphasis on practical solutions that function in real-world clinical environments.

What is the importance of standardizing imaging protocols in this FOA?

Standardized protocols help ensure that quantitative measurements are consistent and comparable across scanners, sites, and trials. This supports validation and broader adoption of imaging-based response metrics.

Why does the FOA mention imaging metadata?

Consistent acquisition parameters, reconstruction settings, and data descriptions (metadata) are essential for making quantitative imaging results comparable across different scanners, sites, and studies. The FOA emphasizes harmonizing both measurements and supporting metadata.

Is this opportunity focused on clinical decision making or exploratory research?

The stated aim is to improve quantitative response assessment in a way that is clinically useful and can better inform real clinical decision making, rather than being limited to exploratory research.

What is the funding mechanism for PAR-11-150?

The mechanism is a U01 cooperative agreement, which generally indicates substantial scientific and programmatic involvement by NIH staff compared to a standard research project grant.

What is the maximum award amount listed for this opportunity?

The award ceiling is listed as $500,000.

Is cost sharing required?

No. Cost sharing is not required.

What NIH program areas does this opportunity align with?

It aligns with areas such as cancer detection and diagnosis research, cancer treatment research, and cancer center support.

Which CFDA numbers are associated with this opportunity?

The opportunity lists CFDA numbers 93.394, 93.395, and 93.397.

What kinds of organizations are eligible to apply?

Eligibility is broad and includes universities (public and private), nonprofit organizations (including 501(c)(3) and certain non-501(c)(3) entities), small businesses, for-profit entities other than small businesses, state and local governments, tribal governments and tribal organizations, independent school districts, public housing authorities, and other specified institutions.

Are minority-serving institutions included in the eligibility list?

Yes. The eligibility list explicitly includes certain minority-serving institutions, such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, and Alaska Native and Native Hawaiian-serving institutions.

Are faith-based or community-based organizations eligible?

Yes. Faith-based or community-based organizations are explicitly included in the eligibility list.

Are foreign organizations or international components allowed?

Yes. Foreign organizations and non-U.S. components of U.S. organizations are allowed, indicating international participation is permissible when aligned with the FOA requirements.

Is industry participation required?

No. The FOA strongly encourages, but does not require, involvement of industrial partners.

Why does the FOA encourage industrial partners?

Industrial involvement is encouraged to support tools and workflows that can be adopted broadly, integrate with commercial systems, and potentially scale beyond a single institution.

What is the Quantitative Imaging Network (QIN), and how does it relate to this award?

A key feature of the program is that awardees will join the Quantitative Imaging Network (QIN), a broader collaborative effort where funded groups share ideas, compare approaches, and work toward validation and standardization of quantitative imaging methods and related metadata.

What collaboration expectations come with participation in the QIN?

Through the QIN, funded teams are expected to share ideas, compare approaches, and work toward validation and standardization. The emphasis is on interoperable methods and common standards that can be tested and harmonized across the community, rather than isolated tools that only work within one lab.

Does the FOA encourage multidisciplinary teams?

Yes. Because quantitative response imaging spans oncology, radiology, medical physics, image analysis, and biostatistics, the FOA anticipates strong applications will be multidisciplinary and encourages teams that include oncologists along with clinical and basic imaging scientists.

What is the overall emphasis of the program in practical terms?

The emphasis is on accelerating practical, standardized quantitative imaging methods that fit into clinical workflows and can be deployed in early-phase cancer therapy trials, with a strong focus on reliability, validation, interoperability, and cross-site comparability.

How is this funding opportunity categorized?

It is categorized as discretionary funding within health-related activities.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Centers for Education and Research on Therapeutics (CERTs) Scientific Forum (U19)

Previous opportunity: Bridging Cultures Through Film

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 11 150

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 11 150) also looked into and applied for these:

Funding Opportunity
Strategic Partnering to Evaluate Cancer Signatures SPECS II (U01) Apply for PAR 11 151

Funding Number: PAR 11 151
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $680,000
The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01) Apply for PAR 11 152

Funding Number: PAR 11 152
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Basic Cancer Research in Cancer Health Disparities (U01) Apply for PAR 11 156

Funding Number: PAR 11 156
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $250,000
Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01) Apply for PAR 11 146

Funding Number: PAR 11 146
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Exploring Drugs of Abuse and Transgenerational Phenotypes (R01) Apply for RFA DA 12 006

Funding Number: RFA DA 12 006
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Biomarkers of Infection Associated Cancers (R01) Apply for PA 11 158

Funding Number: PA 11 158
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Biomarkers of Infection Associated Cancers (R21) Apply for PA 11 159

Funding Number: PA 11 159
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $275,000
Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01) Apply for PA 11 160

Funding Number: PA 11 160
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R21) Apply for PA 11 161

Funding Number: PA 11 161
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R01) Apply for PA 11 162

Funding Number: PA 11 162
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R21) Apply for PA 11 163

Funding Number: PA 11 163
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R03) Apply for PA 11 164

Funding Number: PA 11 164
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $50,000
Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (UM1) Apply for PAR 11 167

Funding Number: PAR 11 167
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Limited Competition for Competitive Revision Applications to Accelerate and Enhance Collaborative Translational Science (UL1) Apply for RFA RR 11 004

Funding Number: RFA RR 11 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Short Term Research Enhancement Opportunities for Veterinarians (K18) Apply for RFA RR 11 002

Funding Number: RFA RR 11 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development Program Projects for Substance Related Disorders (P01) Apply for RFA DA 12 005

Funding Number: RFA DA 12 005
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Research Education Program for Laboratory Animal Medicine Veterinarians (R25) Apply for RFA RR 11 003

Funding Number: RFA RR 11 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Systems Biology Approaches in HIV/AIDS and Substance Use (R01) Apply for RFA DA 12 009

Funding Number: RFA DA 12 009
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $650,000
National Cooperative Drug Discovery and Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (UM1) Apply for PAR 11 206

Funding Number: PAR 11 206
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19) Apply for PAR 11 207

Funding Number: PAR 11 207
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 11 150", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.